Holen Sie sich die Stockscreener-App
4.03
19.72%
-0.99
Handel nachbörslich:
4.15
0.12
+2.98%
Finanzdaten der Sonnet Biotherapeutics Holdings Inc-Aktie (SONN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
1.00 | - | - | - |
Operating Expenses
|
9.87%
4.2294
|
3.8494 | 3.1734 | 3.5287 | 3.8686 |
| Benefits Costs and Expenses |
12.77%
3.4911
|
4.0023 | -4.3273 | 3.5056 | 0.8217 |
| Costs And Expenses |
1.85%
4.0765
|
4.0023 | 3.1734 | 3.5287 | 3.8686 |
| Operating Income/Loss |
48.43%
-4.2294
|
-2.8494 | -3.1734 | -3.5287 | -3.8686 |
| Income/Loss From Continuing Operations Before Tax |
16.28%
-3.4911
|
-3.0023 | 4.3273 | -3.5056 | 0.3654 |
| Income/Loss From Continuing Operations After Tax |
10.45%
-3.4911
|
-3.1607 | -3.1286 | -3.5056 | 0.3654 |
|
Net Income/Loss
|
10.45%
-3.4911
|
-3.1607 | -3.1286 | -3.5056 | 0.3654 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
93.87%
3.9216
|
2.0228 | -3.8266 | 5.0375 | 4.6177 |
| Diluted Average Shares |
93.87%
3.9216
|
2.0228 | -3.8266 | 5.0375 | 4.8858 |
| Basic Earnings Per Share |
42.95%
-0.89
|
-1.56 | -10.39 | -0.70 | 0.08 |
| Diluted Earnings Per Share |
42.95%
-0.89
|
-1.56 | -10.39 | -0.70 | 0.07 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):